The hub genes identified, which include GSK3B, BCL2, MAO-B, CYP1A2, and GSTM2 represent critical nodes within the protein network involved in the therapeutic potential of resveratrol in PD. This evidence concerns the gene CYP1A2 and Parkinson disease.